...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM thoughts

Question

Is the 10 million share financing being done in ZEL or in ZCC where it will reduce our royalties?

All of these questions should be forwarded to the respective companies this week so that they can have most of the answers covered in the presentations.

Bear do I recall you sending a list of questions into the companies in years gone by?

tada

Share
New Message
Please login to post a reply